Analysts Spotlight Nike and BSX as Top Trending Stocks Amid Earnings and Acquisition News
Nike dominates analyst attention with 22 fresh ratings following its Q1 earnings release, carrying a Moderate Buy consensus and 14.3% projected upside. The sportswear giant's $84.80 average price target reflects confidence in its global athletic apparel leadership.
Boston Scientific surges into focus after sealing its $88 million BioEn acquisition, triggering 18 analyst evaluations in 72 hours. The medical device maker's strategic expansion continues to draw institutional scrutiny.